Goyal et al. developed a 3D-QSAR model using 38 thiazolyl-pyrazoline compounds against EGFR, which is a target associated with NSCLC, and obtained two novel inhibitors by screening ZINC libraries [5]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.